🔗 Share this article Social Media Content Creators Fueling Parallel Trade for Unlicensed Weight-Loss Drug An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings. Experimental Treatment Gaining Traction Online The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes. Active Trade on Messaging Platforms Additionally, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases. Understanding Retatrutide Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic. Healthcare Experts Express Concerns However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source. Some experts said the popularity for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro. Regulatory Position and Implementation Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations. Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking fines, legal action or prison. Service Response and Material Removal Based on TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures. Digital Marketplace Activities Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home. After moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience. Product Information and Costs Inside these groups, posts display dark colored parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.” Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”. Platform Oversight and Security Measures A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Professional Warnings “People are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U. A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said. Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.” Producer Position A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to possibly serious health risks”.